Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRC | Q99895 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TYMP | P19971 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6413165 | 0.98 | CTRC (0.43) | CTRCTYRHTTNPC1HPGD | |
| Phosphine SCHEMBL6673547 | 0.96 | CTRC (0.42) | CTRCTYRHTTNPC1HPGD | |
| Ammonia Solution, Strong SCHEMBL3782696 | 0.92 | TYR (0.47) | CTRCTYRHTTCYP3A4TYMP | |
| Ammonia Solution, Strong SCHEMBL7027226 | 0.92 | TYR (0.47) | CTRCTYRHTTCYP3A4TYMP | |
| Ammonia Solution, Strong SCHEMBL20163276 | 0.92 | TYR (0.47) | CTRCTYRHTTCYP3A4TYMP | |
| Phosphine SCHEMBL20163265 | 0.88 | TYR (0.47) | CTRCTYRHTTCYP3A4TYMP | |
| Phosphine SCHEMBL1535934 | 0.88 | TYR (0.47) | CTRCTYRHTTCYP3A4TYMP | |
| SCHEMBL4633219 | 0.87 | TYR (0.50) | CTRCTYRHTTNPC1HPGD | |
| SCHEMBL30044969 | 0.87 | TYR (0.50) | CTRCTYRHTTNPC1HPGD | |
| Ammonia Solution, Strong SCHEMBL623058 | 0.83 | PRKCI (0.32) | HPGDTYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119506974-A | Method for recovering tungsten carbide and cobalt from waste tungsten-cobalt hard alloy | 赣州有色冶金研究所有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-117986239-A | Irbesartan preparation method | 珠海润都制药股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-117623912-A | Method for extracting crocetin by deep eutectic solvent conversion | 北京工商大学 | 2024-03-01 | — | — | CN | claimed |
| US-20130072682-A1 | PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | ACTAVIS GROUP PTC EHF (IS) | 2013-03-21 | — | — | US | claimed |
| US-20110224437-A1 | PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | ACTAVIS GROUP PTC EHF (IS) | 2011-09-15 | — | — | US | claimed |
| WO-2010023561-A9 | PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | ACTAVIS GROUP PTC EHF (IS) | 2011-08-04 | — | — | WO | claimed |
| EP-2334679-A1 | PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | Actavis Group PTC EHF (IS) | 2011-06-22 | — | — | EP | claimed |
| WO-2010023561-A1 | PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | ACTAVIS GROUP PTC EHF (IS) | 2010-03-04 | — | — | WO | claimed |
| US-20060074217-A1 | Ketone-aldehyde resins having low water content, high thermal stability and yellowing resistance | DEGUSSA AG (DE) | 2006-04-06 | — | — | US | claimed |
| US-6465576-B1 | Fluoroelastomer compositions and articles made therefrom | DYNEON LLC | 2002-10-15 | — | — | US | claimed |
| EP-1194462-A1 | FLUOROELASTOMER COMPOSITIONS AND ARTICLES MADE THEREFROM | Dyneon LLC (US) | 2002-04-10 | — | — | EP | claimed |
| WO-2001002448-A1 | FLUOROELASTOMER COMPOSITIONS AND ARTICLES MADE THEREFROM | DYNEON LLC (US) | 2001-01-11 | — | — | WO | claimed |
| JP-62030739-A | — | — | None | — | — | JP | disclosed |
| EP-4640741-A1 | ELECTRONIC SUBSTRATE MATERIAL, RESIN AND METHOD FOR PRODUCING RESIN | Idemitsu Kosan Co.,Ltd. (JP) | 2025-10-29 | — | — | EP | disclosed |
| EP-4640743-A1 | ELECTRONIC BOARD MATERIAL, RESIN, AND METHOD FOR PRODUCING RESIN | Idemitsu Kosan Co.,Ltd. (JP) | 2025-10-29 | — | — | EP | disclosed |
| EP-4640742-A1 | ELECTRONIC SUBSTRATE MATERIAL, RESIN, AND METHOD FOR MANUFACTURING RESIN | Idemitsu Kosan Co.,Ltd. (JP) | 2025-10-29 | — | — | EP | disclosed |
| EP-0154460-A2 | Fluoroelastomer compositions containing fluoroaliphatic sulfonamides as curing agents | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-09-11 | — | — | EP | disclosed |
| EP-0101163-A2 | Preparation of pigmentary grade pigment from crude pigment | CIBA-GEIGY AG (CH) | 1984-02-22 | — | — | EP | disclosed |
| US-4328170-A | Process for preparing an α-cyanoacrylate | MATSUMOTO SEIYAKU KOGYO KABUSHIKI KAISHA (JP) | 1982-05-04 | — | — | US | disclosed |
| EP-0012866-A1 | New 3H-naphtho(1,2-d)imidazoles, processes for preparing them, compounds for use as antiinflammatory and antimicrobial agents and compositions for that use containing them | GRUPPO LEPETIT S.P.A. (IT) | 1980-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224437-A1 | PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | TET2, NOX4, CYP3A7 | CTRC 1598/4885TYR 687/4885HTT 600/4885 |
| US-20130072682-A1 | PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | TET2, NOX4, CYP3A7 | CTRC 1598/4885TYR 687/4885HTT 600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.